CV Sciences Inc enters new 600000 secured loan agreement with institutional investor
CV Sciences, Inc. has entered into a new secured financing agreement with an institutional investor, issuing a promissory note with an original principal amount of $600,000. The transaction, which closed on October 7, 2025, involved an original issuance discount of $150,000 and an additional $150,000 payment related to a modification of a previous agreement, resulting in net proceeds of $300,000 for the company. The note, due on April 6, 2027, requires monthly repayments starting April 6, 2026, and is secured by all company and subsidiary assets, including intellectual property. No interest will accrue unless there is an event of default, and early repayment within six months offers an 8% discount on the outstanding balance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CV Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-237188), on October 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.